| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193350 | Annals of Allergy, Asthma & Immunology | 2007 | 7 Pages |
Abstract
In this study, intranasal ciclesonide treatment was associated with significant reductions in nasal symptoms and appreciable improvements in health-related quality of life in adult and adolescent patients with PAR. Ciclesonide was well tolerated, with a safety profile comparable with that of placebo.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Eli O. MD, Sudeesha PhD, Nancy MS, Mark A. MD, Crystal PhD, William MD, Craig MD,